These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 3904430)
1. Aluminum and phosphate: the double bind. Kaye M; Gagnon R Am J Kidney Dis; 1985 Nov; 6(5):365-7. PubMed ID: 3904430 [No Abstract] [Full Text] [Related]
2. Aluminum metabolism and toxicity in renal failure: a review. Mayor GH; Lohr TO; Sanchez TV J Environ Pathol Toxicol Oncol; 1985; 6(1):43-50. PubMed ID: 3906081 [No Abstract] [Full Text] [Related]
3. Aluminum and the pathogenesis of dialysis encephalopathy. Arieff AI Am J Kidney Dis; 1985 Nov; 6(5):317-21. PubMed ID: 3904424 [No Abstract] [Full Text] [Related]
4. Water content of aluminum, dialysis dementia, and osteomalacia. Wills MR; Savory J Environ Health Perspect; 1985 Nov; 63():141-7. PubMed ID: 3908086 [TBL] [Abstract][Full Text] [Related]
5. [Toxic effect of aluminum in chronic renal failure]. Głuszek J Pol Tyg Lek; 1987 Nov; 42(48):1499-502. PubMed ID: 3451199 [No Abstract] [Full Text] [Related]
7. Aluminum intoxication of bone in renal failure--fact or fiction? Malluche HH; Faugere MC; Smith AJ; Friedler RM Kidney Int Suppl; 1986 Feb; 18():S70-3. PubMed ID: 3458000 [No Abstract] [Full Text] [Related]
8. Role of plasma aluminum in the detection and prevention of aluminum toxicity. Winney RJ; Cowie JF; Robson JS Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005 [No Abstract] [Full Text] [Related]
9. Clearance of aluminum by hemodialysis: effect of desferrioxamine. Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984 [No Abstract] [Full Text] [Related]
10. Aluminum and renal bone disease in Australia. Dunstan CR; Evans RA Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999 [No Abstract] [Full Text] [Related]
11. Effect of aluminum on bone and cell localization. Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993 [No Abstract] [Full Text] [Related]
13. Aluminum accumulation in individuals with normal renal function. Ott SM Am J Kidney Dis; 1985 Nov; 6(5):297-301. PubMed ID: 3933333 [TBL] [Abstract][Full Text] [Related]
14. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH. Nebeker HG; Andress DL; Milliner DS; Ott SM; Alfrey AC; Slatopolsky EA; Sherrard DJ; Coburn JW Kidney Int Suppl; 1986 Feb; 18():S96-9. PubMed ID: 3458006 [No Abstract] [Full Text] [Related]
15. Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays. Andress DL; Endres DB; Ott SM; Sherrard DJ Kidney Int Suppl; 1986 Feb; 18():S87-90. PubMed ID: 3458004 [No Abstract] [Full Text] [Related]
16. Risk factors in aluminum toxicity in children with chronic renal failure. Santos F; Massie MD; Chan JC Nephron; 1986; 42(3):189-95. PubMed ID: 3511396 [No Abstract] [Full Text] [Related]
17. Clinical and biochemical features of aluminum-related bone disease. Ihle BU; Becker GJ; Kincaid-Smith PS Kidney Int Suppl; 1986 Feb; 18():S80-6. PubMed ID: 3458003 [No Abstract] [Full Text] [Related]
18. Sporadic aluminum osteomalacia: identification of patients at risk. Turner MW; Ardila M; Hutchinson T; Prichard S; Barré PE; Beauvais J; Kaye M Am J Kidney Dis; 1988 Jan; 11(1):51-6. PubMed ID: 3337100 [TBL] [Abstract][Full Text] [Related]
19. Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease. Sherrard DJ; Walker JV; Boykin JL Am J Kidney Dis; 1988 Aug; 12(2):126-30. PubMed ID: 3400633 [TBL] [Abstract][Full Text] [Related]
20. Fracture healing with deferoxamine therapy in a patient with aluminum-associated osteomalacia. Phelps KR; Einhorn TA; Vigorita VJ; Lundin AP; Friedman EA ASAIO Trans; 1986; 32(1):198-200. PubMed ID: 3778712 [No Abstract] [Full Text] [Related] [Next] [New Search]